Alpha blockers increase CHF risk in older hypertensive patients.
- Published in:
- Formulary, 2005, v. 40, n. 2, p. 42
- Publication type:
- Article
Works matching IS 1082801X AND DT 2005 AND VI 40 AND IP 2
Results: 11
1
2
FDA actions in brief.
- Published in:
- Formulary, 2005, v. 40, n. 2, p. 40
- Publication type:
- Article
3
Pipeline preview.
- Published in:
- Formulary, 2005, v. 40, n. 2, p. 39
- Publication type:
- Article
4
New molecular entities.
- Published in:
- Formulary, 2005, v. 40, n. 2, p. 39
- Publication type:
- Article
5
Update on the treatment of benign prostatic hyperplasia.
- Published in:
- 2005
- By:
- Publication type:
- Journal Article
6
Focus on...cilansetron. A novel 5-HT3 receptor antagonist for the treatment of irritable bowel syndrome.
- Published in:
- 2005
- By:
- Publication type:
- Journal Article
7
Update on the treatment of benign prostatic hyperplasia.
- Published in:
- Formulary, 2005, v. 40, n. 2, p. 50
- By:
- Publication type:
- Article
8
Clarification.
- Published in:
- 2005
- Publication type:
- Correction Notice
9
Cilansetron.
- Published in:
- Formulary, 2005, v. 40, n. 2, p. 44
- By:
- Publication type:
- Article
10
FDA committees to review COX-2 inhibitor risk-benefit profile.
- Published in:
- Formulary, 2005, v. 40, n. 2, p. 42
- Publication type:
- Article
11
First-time generic approvals.
- Published in:
- Formulary, 2005, v. 40, n. 2, p. 40
- Publication type:
- Article